Connect with us
Geared for growth, the CBD industry has revitalized the marijuana sector, owing to its numerous benefits and diversity in its various product lines.
Now that Trump’s trade wars have reached the CBD industry, how will it react? And will it be able to stay afloat?
Companies are now pushing for more diversification in their products as the CBD industry observes growth that can keep the sector alive for a long time.
With the growing attention the cannabis industry is receiving these days, now is the best time to think about investing in this sector.
The alcoholic beverage market will be worth $1.5 trillion by 2022, while the marijuana industry is projected to arrive at $146.4 billion by 2024.
With its legalization in many states, the cannabis industry is experiencing a boost in medical marijuana, with cannabidiol oil showing the most promise.
GW Pharmaceuticals’ Epidiolex is the first FDA-approved cannabis-based drug.
After the Senate's approval, the Canadian government did not accept some of the amendments in the Cannabis Act.
PotNetwork Holdings, Inc. (OTCMKTS:POTN) plans to expand and make its products available to underdeveloped sectors.
A recent study revealed that a significant drop in binge drinking ratings were observed among states which permit the use of recreational cannabis.